Erste Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-486,374
Closed -$89.5M 609
2025
Q4
$89.5M Sell
486,374
-4,950
-1% -$868K 0.75% 27
2025
Q3
$72.8M Sell
491,324
-14,657
-3% -$2.22M 0.7% 31
2025
Q2
$70.7M Buy
505,981
+25,657
+5% +$3.6M 0.59% 36
2025
Q1
$70.7M Hold
480,324
0.91% 25
2024
Q4
$63.2M Buy
480,324
+15,000
+3% +$2.1M 0.77% 31
2024
Q3
$72.4M Sell
465,324
-10,000
-2% -$1.61M 0.87% 26
2024
Q2
$74.2M Sell
475,324
-15,000
-3% -$2.26M 0.98% 21
2024
Q1
$66.6M Buy
490,324
+60,500
+14% +$8.01M 0.91% 24
2023
Q4
$57.9M Sell
429,824
-30,000
-7% -$3.9M 0.85% 27
2023
Q3
$62.2M Buy
459,824
+78,000
+20% +$10.7M 1.07% 14
2023
Q2
$54.5M Buy
381,824
+300,000
+367% +$44.1M 0.96% 17
2023
Q1
$11.3M Hold
81,824
0.22% 121
2022
Q4
$11.1M Buy
81,824
+6,100
+8% +$765K 0.24% 117
2022
Q3
$8.32M Hold
75,724
0.19% 143
2022
Q2
$10.2M Buy
75,724
+8,000
+12% +$1.05M 0.23% 120
2022
Q1
$9.09M Buy
67,724
+10,300
+18% +$1.24M 0.17% 150
2021
Q4
$6.74M Sell
57,424
-25,750
-31% -$3.03M 0.12% 178
2021
Q3
$9.93M Buy
83,174
+18,174
+28% +$2.12M 0.2% 134
2021
Q2
$7.82M Hold
65,000
0.16% 153
2021
Q1
$6.5M Hold
65,000
0.16% 158
2020
Q4
$6.49M Buy
+65,000
New +$6.88M 0.18% 145

Other funds holding AZN

Erste Asset Management's AZN Position: Q1 2026 in Review

Erste Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 486,374 shares — an estimated $89.5M sold.

Erste Asset Management first reported a position in AZN in Q4 2020 and held it in 21 quarters. The position peaked at $89.5M in Q4 2025. 1,386 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Erste Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Erste Asset Management sold 486,374 AstraZeneca shares in Q1 2026, an estimated $89.5M.
  • Erste Asset Management first reported a position in AstraZeneca in Q4 2020 and held it in 21 quarters.
  • Erste Asset Management's AstraZeneca position peaked at $89.5M in Q4 2025.
  • 1,386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.